It did not cut the prices of any blockbusters like the cancer treatment Keytruda or the diabetes drug Januvia.
Mark Merritt said the real problem was the high prices set by drugmakers. “Getting rid of rebates and other price concessions would leave patients and payers, including Medicaid and Medicare, at the mercy of drug manufacturers’ pricing strategies,” Mr. Merritt
A World Without Pharmacy Benefit Companies… …Means Employers Would Have to Go it Alone Pharmacy benefit companies play an important and unique role in the drug supply and payment chain. While they are best known for lowering drug costs through
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
(Washington, D.C.) — In honor of World Diabetes Day, the Pharmaceutical Care Management Association (PCMA) has launched a new phase of the OnYourRxSide campaign that showcases how pharmacy benefit managers, PBMs, are working to improve the lives of patients living
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today issued the following statement on a new research paper, “Ending Pay for PBM Performance: Consequences for Prescription Drug Prices, Utilization, and Government Spending,” authored by University of Chicago Professor of
Alex Brill and Angela Banks Dive into the Critical Need for Competition, Big Drug Companies’ Abuse of the Patent System, and Biosimilar Adoption In case you missed it, Angela Banks, Vice President of Policy for the Pharmaceutical Care Management Association
The Value of Pharmacy Benefit Management PBMs Create $145 Billion in Value Annually Groundbreaking research by University of Chicago Economics Professor Casey Mulligan describes the services that pharmacy benefit managers (PBMs) provide in the healthcare marketplace to patients, health plans,
New Research Paper Demonstrates Declining Biosimilars Prices and Increasing Health Plan Coverage (Washington, D.C.) — Pharmacy benefit managers, PBMs, support the proliferation and use of biosimilars. A robust biosimilar market will increase competition for biologic drugs and provide added choice
©2024 PCMA. All Rights Reserved.
